{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:28:49Z","timestamp":1787243329727,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crad.2026.107426","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:40:02Z","timestamp":1783352402000},"page":"107426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the utility of qualitative and quantitative multiparametric magnetic resonance imaging (MRI) parameters in distinguishing luminal and nonluminal breast cancer subtypes"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-3322","authenticated-orcid":false,"given":"S.","family":"Mohakud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pavithra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Muduly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.D.","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bhaduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Korrapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21037\/qims.2019.11.16","article-title":"The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.crad.2026.107426_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ctrv.2018.04.015","article-title":"Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer","volume":"67","author":"Cejalvo","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.crad.2026.107426_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/11782234221103504","article-title":"Preoperative breast magnetic resonance imaging as a predictor of response to neoadjuvant chemotherapy","volume":"16","author":"Browne","year":"2022","journal-title":"Breast Cancer;(Auckl)"},{"issue":"12","key":"10.1016\/j.crad.2026.107426_bib4","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/medicina58121716","article-title":"Multiparametric MRI features of breast cancer molecular subtypes","volume":"58","author":"Szep","year":"2022","journal-title":"Medicina"},{"issue":"51","key":"10.1016\/j.crad.2026.107426_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028109","article-title":"The diagnostic performance of dynamic contrast-enhanced MRI and its correlation with subtypes of breast cancer","volume":"100","author":"Li","year":"2021","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.crad.2026.107426_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.diii.2024.01.004","article-title":"Multiparametric MRI model to predict molecular subtypes of breast cancer using Shapley additive explanations interpretability analysis","volume":"105","author":"Huang","year":"2024","journal-title":"Diagn Interv Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.crad.2026.107426_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13193-020-01253-w","article-title":"Prevalence of molecular subtypes of breast cancer in India: a systematic review and meta-analysis","volume":"12","author":"Jonnada","year":"2021","journal-title":"Indian J Surg Oncol"},{"issue":"6","key":"10.1016\/j.crad.2026.107426_bib8","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2214\/AJR.14.13666","article-title":"Breast cancer molecular subtype as a predictor of the utility of preoperative MRI","volume":"204","author":"Ha","year":"2015","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-020-05592-8","article-title":"Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner","volume":"181","author":"Panzironi","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.crad.2026.107426_bib10","doi-asserted-by":"crossref","first-page":"1140514","DOI":"10.3389\/fmed.2023.1140514","article-title":"Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer","volume":"10","author":"Huang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.crad.2026.107426_bib11","article-title":"Usefulness of combined advanced dynamic contrast-enhanced and diffusion-weighted MRI over ultrasonography in differentiating cancer from benign lesions in dense breasts","volume":"16","author":"Muthuvel","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21873\/invivo.12717","article-title":"Associations between dynamic contrast enhanced magnetic resonance imaging and clinically relevant histopathological features in breast cancer: a multicenter analysis","volume":"36","author":"Surov","year":"2022","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.crad.2026.107426_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0320240","article-title":"Dynamic contrast-enhanced magnetic resonance imaging parameters combined with diffusion-weighted imaging for discriminating malignant lesions, molecular subtypes, and pathological grades in invasive ductal carcinoma patients","volume":"20","author":"Zhu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2026.107426_bib14","article-title":"Quantitative multiparametric MRI as an imaging biomarker for the prediction of breast cancer receptor status and molecular subtypes","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2026.107426_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mri.2020.12.001","article-title":"Improved discrimination of molecular subtypes in invasive breast cancer: comparison of multiple quantitative parameters from breast MRI","volume":"77","author":"Du","year":"2021","journal-title":"Magnetic Res Imag"},{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jmri.23635","article-title":"Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers","volume":"36","author":"Koo","year":"2012","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"5","key":"10.1016\/j.crad.2026.107426_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.acra.2018.06.014","article-title":"Morphological and semiquantitative kinetic analysis on dynamic contrast enhanced MRI in triple negative breast cancer patients","volume":"26","author":"Gigli","year":"2019","journal-title":"Academic Radiology"},{"key":"10.1016\/j.crad.2026.107426_bib18","article-title":"Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2026.107426_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejrad.2018.09.024","article-title":"Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?","volume":"108","author":"Montemezzi","year":"2018","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib20","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240288","article-title":"Time-dependent diffusion MRI helps predict molecular subtypes and treatment response to neoadjuvant chemotherapy in breast cancer","volume":"313","author":"Wang","year":"2024","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.crad.2026.107426_bib21","first-page":"5100","article-title":"Intravoxel incoherent motion magnetic resonance imaging for breast cancer: a comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol Lett."},{"issue":"8","key":"10.1016\/j.crad.2026.107426_bib22","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00330-012-2425-2","article-title":"Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes","volume":"22","author":"Youk","year":"2012","journal-title":"Eur Radiol"},{"issue":"12","key":"10.1016\/j.crad.2026.107426_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/diagnostics10121090","article-title":"Can MRI biomarkers predict triple-negative breast cancer?","volume":"10","author":"Moffa","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.crad.2026.107426_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000514407","article-title":"Diffusion-weighted imaging of different breast cancer molecular subtypes: a systematic review and meta-analysis","volume":"17","author":"Meyer","year":"2022","journal-title":"Breast Care"},{"issue":"5","key":"10.1016\/j.crad.2026.107426_bib25","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.2214\/AJR.11.7292","article-title":"Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators","volume":"198","author":"Shin","year":"2012","journal-title":"American Journal of Roentgenology"},{"issue":"38","key":"10.1016\/j.crad.2026.107426_bib26","doi-asserted-by":"crossref","first-page":"63405","DOI":"10.18632\/oncotarget.18822","article-title":"Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.crad.2026.107426_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/msp2.45","article-title":"Prediction of genetic profile of breast carcinoma on MRI using a combination of DCE-MRI, DWI, and MR spectroscopy: a prospective observational study","volume":"1","author":"Sharma","year":"2024","journal-title":"Malignancy Spectrum"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:44Z","timestamp":1787242544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S0009926026002023"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107426","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the utility of qualitative and quantitative multiparametric magnetic resonance imaging (MRI) parameters in distinguishing luminal and nonluminal breast cancer subtypes","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107426"}}